| Lipids Management |
1 |
1 |
| Cardiovascular Risk Management |
0 |
1 |
| High HDL Cholesterol |
0 |
1 |
| Coronary Artery Disease (CAD) |
0 |
0.54 |
| Low HDL Cholesterol |
0 |
0.6 |
| Social Determinants of Health |
0 |
0.42 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
1 |
| LDL Cholesterol |
0 |
0.6 |
| Heart |
0 |
0.38 |
| Oregon |
0 |
0.38 |
| Coronary Artery Calcification |
0 |
0.35 |
| Atherosclerosis |
0 |
0.32 |
| Biomarker |
0 |
0.28 |
| Lipoproteins |
0 |
0.28 |
| Cerebrovascular Accident |
0 |
0.21 |
| Osteoarthritis |
0 |
0.21 |
| Artery |
0 |
0.19 |
| Calcium |
0 |
0.19 |
| Exercise |
0 |
0.19 |
| Socioeconomics |
0 |
0.19 |
| Cardiovascular disease |
0 |
0.1 |
| Diet |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Evidence-Based Medicine |
0 |
0.1 |
| Health Care Inequities |
0 |
0.1 |
| Triglycerides |
0 |
0.1 |